# Phase 12 Remediation and Retest Summary

## Decision

The remediation and retest checkpoint passes. All four genuine defects remain Closed after independent corrected-baseline confirmation, all six selected critical regression cases pass, and there is no open Critical or Major defect in the recorded scope.

## Results

| Measure | Result |
|---|---:|
| Confirmed defects reviewed | 4 |
| Managed defect confirmations passed | 4 of 4 |
| Managed regression cases passed | 6 of 6 |
| Managed cycle total | 10 Pass, 0 Fail, 0 Blocked, 0 Not Run |
| Focused automated checks | 12 Pass |
| Complete project suite | 121 Pass |
| Frontend production build | Pass |
| Confirmed defects remaining open | 0 |
| Unauthorized product changes | 0 |

The focused check count is higher than the managed case count because TC-COMPAT-001 executes at three parameterized viewport widths while remaining one approved test case.

## UAT reconciliation

Phase 11 had no failed scenario and no confirmed product defect. UAT-OBS-001 remains a requirement misunderstanding with no product change. UAT-ENH-001 remains a deferred enhancement linked to ENH-002. Neither item is presented as a defect correction or passed retest.

## Product-change statement

Phase 12 did not change application behavior. It consolidated the approved correction chains, re-executed direct confirmations and adjacent regression, and added auditable cycle evidence. This prevents an artificial defect from being created merely to populate the phase.

## Residual limits

- Results describe the recorded local Windows and Brave environment with synthetic data.
- The accessibility confirmations do not constitute certification or a legal-compliance claim.
- The Phase 10 performance result remains bounded to its recorded loopback-only workload.
- Pipeline quality gates and the final release recommendation remain assigned to later phases.

## Checkpoint status

Phase 12 was approved on 2026-08-10. The verified remediation and retest evidence is accepted as the Phase 12 repository checkpoint.
